Cellcept and Conjunctivitis - a phase IV clinical study of FDA data

Summary:

Conjunctivitis is found among people who take Cellcept, especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months.

The phase IV clinical study analyzes which people take Cellcept and have Conjunctivitis. It is created by eHealthMe based on reports of 37,071 people who have side effects when taking Cellcept from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

37,071 people reported to have side effects when taking Cellcept.
Among them, 30 people (0.08%) have Conjunctivitis.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 37,827 Cellcept users for its effectiveness, alternative drugs and more.

What is Conjunctivitis?

Conjunctivitis (pink eye) is found to be associated with 2,159 drugs and 1,579 conditions by eHealthMe.

Number of Cellcept and Conjunctivitis reports submitted per year:

Time on Cellcept when people have Conjunctivitis *:

Gender of people who have Conjunctivitis when taking Cellcept *:

female: 60 %
male: 40 %

Age of people who have Conjunctivitis when taking Cellcept *:

Common drugs people take besides Cellcept *:

Common side effects people have besides Conjunctivitis *:

Diarrhea: 7 people, 23.33%
Fatigue (feeling of tiredness): 6 people, 20.00%
Hypotension (abnormally low blood pressure): 6 people, 20.00%
Breathing Difficulty: 5 people, 16.67%
Mouth Ulcers: 4 people, 13.33%
Drug Ineffective: 4 people, 13.33%
Haemoglobin Decreased: 4 people, 13.33%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 13.33%
Dizziness: 4 people, 13.33%
Leukopenia (less number of white blood cells in blood): 4 people, 13.33%

Common conditions people have *:

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 13.33%
Acidosis (build-up of carbon dioxide in the blood): 2 people, 6.67%
Immunodeficiency Common Variable: 2 people, 6.67%
Gastric Ulcer (stomach ulcer): 2 people, 6.67%
Osteoporosis (bones weak and more likely to break): 2 people, 6.67%
Ocular Pemphigoid (inflammatory autoimmune disorder characterized by blistering lesions that affect mucous membrane covering of eye): 2 people, 6.67%
Humoral Immune Defect (impairment of humoral immunity): 2 people, 6.67%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.33%
Birth Control: 1 person, 3.33%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Conjunctivitis?

Check whether Conjunctivitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Conjunctivitis and when was it recovered:

Conjunctivitis in Cellcept

Expand to all the drugs that have ingredients of mycophenolate mofetil:

Conjunctivitis and drugs with ingredients of mycophenolate mofetil (73 reports)

Alternative drugs to, pros and cons of Cellcept:

Cellcept (37,827 reports)

Common Cellcept side effects:

Diarrhea: 2,176 reports
Fever: 1,957 reports
Drug ineffective: 1,585 reports
Pneumonia: 1,565 reports
Fatigue (feeling of tiredness): 1,555 reports
Breathing difficulty: 1,538 reports
Death: 1,454 reports
Weakness: 1,417 reports

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Conjunctivitis treatments and more:

Conjunctivitis (18,084 reports)

COVID vaccines that are related to Conjunctivitis:

Common drugs associated with Conjunctivitis:

All the drugs that are associated with Conjunctivitis:

Conjunctivitis (2,159 drugs)

Common conditions associated with Conjunctivitis:

Rheumatoid arthritis: 1,148 reports
High blood pressure: 586 reports
Asthma: 531 reports
Osteoporosis: 436 reports

All the conditions that are associated with Conjunctivitis:

Conjunctivitis (1,579 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.